|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases activity |
EXP |
B 581 results in decreased activity of NFKB1 protein |
CTD |
PMID:12085227 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
decreases phosphorylation |
EXP |
B 581 results in decreased phosphorylation of NFKBIA protein |
CTD |
PMID:12085227 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
decreases activity |
EXP |
B 581 results in decreased activity of RELA protein |
CTD |
PMID:12085227 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
|
G |
AGT |
angiotensinogen |
multiple interactions |
ISO |
[icatibant co-treated with Captopril] inhibits the reaction [bisphenol A results in increased expression of AGT protein] |
CTD |
PMID:38027817 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
multiple interactions |
EXP ISO |
icatibant binds to and results in decreased activity of BDKRB2 protein; icatibant inhibits the reaction [FR 190997 binds to and results in increased activity of BDKRB2 protein]; icatibant inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] icatibant binds to and results in decreased activity of BDKRB2 protein; icatibant inhibits the reaction [KNG1 protein modified form binds to BDKRB2 protein] [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Chondroitin Sulfates; [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Streptozocin; [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Vincristine; [icatibant results in decreased activity of BDKRB2 protein] inhibits the reaction [Valsartan results in increased abundance of Cyclic GMP]; [icatibant results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to benazepril; [icatibant results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Valsartan; icatibant binds to and results in decreased activity of BDKRB2 protein; icatibant inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] |
CTD |
PMID:10666510 PMID:12727271 PMID:15140628 PMID:16982965 PMID:17347322 PMID:17989505 PMID:21436127 PMID:24975837 PMID:30685357 More...
|
|
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of ICAM1 protein]] |
CTD |
PMID:16401625 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
[icatibant co-treated with Captopril] inhibits the reaction [bisphenol A results in increased expression of IL6 protein] |
CTD |
PMID:38027817 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
KLK1 |
kallikrein 1 |
multiple interactions |
ISO |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of ICAM1 protein]]; icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of TGFB1 protein]]; icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased phosphorylation of MAPK8 protein]]; icatibant inhibits the reaction [KLK1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:16401625 |
|
NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions decreases activity |
EXP ISO |
icatibant inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] icatibant inhibits the reaction [KNG1 protein modified form binds to BDKRB2 protein] icatibant results in decreased activity of KNG1 [icatibant co-treated with Captopril] inhibits the reaction [bisphenol A results in increased expression of KNG1 protein]; icatibant inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates]; icatibant inhibits the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; icatibant inhibits the reaction [KNG1 results in increased expression of PTGS2 mRNA]; icatibant inhibits the reaction [KNG1 results in increased secretion of TAC1 protein] |
CTD |
PMID:1334751 PMID:15140628 PMID:15750287 PMID:16696851 PMID:17347322 PMID:22198006 PMID:30685357 PMID:38027817 More...
|
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases activity multiple interactions |
EXP |
icatibant results in increased activity of MAPK3 protein FR 173657 inhibits the reaction [icatibant results in increased activity of MAPK3 protein] |
CTD |
PMID:11139431 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased phosphorylation of MAPK8 protein]] |
CTD |
PMID:16401625 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
PLAT |
plasminogen activator, tissue type |
decreases expression |
EXP |
icatibant results in decreased expression of PLAT protein |
CTD |
PMID:16321614 |
|
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
icatibant inhibits the reaction [KNG1 results in increased expression of PTGS2 mRNA] |
CTD |
PMID:15750287 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
TAC1 |
tachykinin precursor 1 |
multiple interactions |
ISO |
icatibant inhibits the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; icatibant inhibits the reaction [KNG1 results in increased secretion of TAC1 protein] |
CTD |
PMID:16696851 PMID:22198006 |
|
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
[icatibant co-treated with Captopril] inhibits the reaction [bisphenol A results in increased expression of TGFB1 protein]; icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of TGFB1 protein]] |
CTD |
PMID:16401625 PMID:38027817 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
[icatibant co-treated with Captopril] inhibits the reaction [bisphenol A results in increased expression of TNF protein] |
CTD |
PMID:38027817 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
multiple interactions |
EXP |
telaprevir inhibits the reaction [CYP3A4 protein results in increased metabolism of Simvastatin] |
CTD |
PMID:24927617 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|